The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man

Clinical Endocrinology

Volumn 45, Issue 5, 1996, Pages 543-551

  Micic, Dragan ^a   Popovic, Vera ^a   Kendereski, Aleksandra ^a   Peino, Roberto ^b   Dieguez, Carlos ^b   Casanueva, Felipe F ^b,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; SERMORELIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS FUNCTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029822968     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00841.x     Document Type: Article

References (43)

1. 2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. Journal of Clinical Endocrinology and Metabolism, 77, 842-845.
2. Arvat, E., Gianotti, L., Grottoli, S., Imbimbo, B.P., Lenaerts, V., Deghenghi, R., Camanni, F. & Ghigo, E. (1994) Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Journal of Clinical Endocrinology and Metabolism, 79, 1440-1443.
3. 2 stimulate growth hormone release through distinct receptor sites. Journal of Endocrinology, 129, 11-19.
4. Bowers, C.Y., Momany, F.A., Chang, D., Hong, A. & Chang, K. (1980) Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology, 106, 663-667.
5. Bowers, C.Y., Momany, F.A., Reynolds, G.A. & Hong, A. (1984) On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114, 1537-1545.
6. Bowers, C.Y., Reynolds, G.A., Durham, D., Barrera, C.M., Pezzoli, S.S. & Thorner, M.O. (1990) Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism, 70, 975-982.
7. Bowers, C.Y., Sartor, A.O., Reynolds, G.A. & Badger, T.M. (1991) On the actions of the growth hormone-releasing hexapeptide, GHRP-6. Endocrinology, 128, 2027-2035.
8. Cacciari, E., Tassoni, P., Cicognani, A., Pirazolli, P., Salardi, S., Balsamo, A., Cassio, A., Zucchini, S., Colli, C., Tassinari, D., Tani, G. & Gualardi, S. (1994) Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. Journal of Clinical Endocrinology Metabolism, 79, 1663-1669.
9. Casanueva, F.F. (1992) Physiology of growth hormone secretion and action. Endocrinology and Metabolism Clinics of North America, 21, 483-517.
10. Casanueva, F.F. (1995) The Spanish experience on the rationalization of expensive treatments for endocrine disorders. Journal of Endocrinology, 144 (Suppl. S42) (abstr.).
11. Clark, R.G., Carlsson, L.M.S., Trojnar, J. & Robinson, I.C.A.F. (1989) The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. Journal of Neuroendocrinology, 1, 249-255.
12. Codd, E.E., Shu, A.Y.L. & Walker, R.F. (1989) Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology, 28, 1139-1144.
13. Cordido, F., Peñalva, A., Dieguez, C. & Casanueva, F.F. (1993) Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity. Journal of Clinical Endocrinology and Metabolism, 76, 819-823.
14. Cuttler, L. (1987) Growth disorders in childhood. Pediatrician, 14, 109-120.
15. De Bell, W.K., Pezzoli, S.S. & Thorner, M.O. (1991) Growth hormone (GH) secretion during continuous infusion of GH releasing peptide: Partial response attenuation. Journal of Clinical Endocrinology and Metabolism, 72, 1312-1316.
16. De Boer, H., Blok, G.-J. & Van der Veen, E.A. (1995). Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
17. Dieguez, C. & Casanueva, F.F. (1995) Influence of metabolic substrates and obesity on growth hormone secretion. Trends in Endocrinology Metabolism, 6, 55-59.
18. Dieguez, C., Page, M.D. & Scanlon, M.F. (1988) Growth hormone neuroregulation and its alterations in disease states. Clinical Endocrinology, 28, 109-143.
19. Frasier, S.D. & Lippe, B.M. (1990) Clinical review 11: the rational use of growth hormone during childhood. Journal of Clinical Endocrinology and Metabolism, 71, 269-273.
20. Chigo, E., Arvat, E., Gianotti, L., Imbimbo, B.P., Lenaerts, V., Deghenghi, R. & Camanni, F. (1994) Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism, 78, 693-698.
21. Goth, M.I., Lyons, C.E., Canny. B.J. & Thorner, M.O. (1992) Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology, 130, 939-944.
22. Granada, M.L., Sanmarti, A., Lucas, A., Salinas, I., Cuatrecasas, J.M., Foz, M., Carrascosa, A. & Audí, L. (1992) Clinical usefulness of urinary growth hormone measurements in normal and short children according to different expressions of urinary growth hormone data. Pediatric Research, 32, 73-76.
23. Guillaume, V., Magnan, E., Cataldi, M., Dutour, A., Sauze, N., Renard, M., Razapindraibe, H., Conte-Devolx, B., Deghenghi, R., Lenaerts, V. & Oliver, C. (1994) Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing peptide in sheep. Endocrinology, 135, 1073-1076.
24. Hindmarsh, P.C. & Brook, C.G.D. (1995) Short stature and growth hormone deficiency. Clinical Endocrinology, 43, 133-142.
25. Korbonits, M. & Grossman, A.B. (1995) Growth hormone-releasing peptide and its analogues: novel stimuli to growth hormone release. Trends in Endocrinology and Metabolism, 6, 43-49.
26. Korbonits, M., Trainer, J.P. & Besser, G.M. (1995) The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clinical Endocrinology, 43, 365-371.
27. Leal, A., Garcia, E., Astorga, R., Casanueva, F.F. & Dieguez, C. (1995) Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency. European Journal of Endocrinology, 132, 712-715.
28. Leal, A., Pumar, A., Garcia, E., Dieguez, C. & Casanueva, F.F. (1994) Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clinical Endocrinology, 41, 649-654.
29. Micic, D., Popovic, V., Kendereski, A., Macut, D., Casanueva, F.F. & Dieguez, C. (1995) Growth hormone secretion after the administration of GHRP-6, or GHRP-6 combined with GHRH does not decline in late adulthood. Clinical Endocrinology, 42, 191-194.
30. Momany, F.A., Bowers, C.Y., Reynolds, G.A., Hong, A. & Newlander, K. (1984) Conformational energy studies and in vitro activity data on active GH releasing peptides. Endocrinology, 144, 1531-1536.
31. Peñalva, A., Carballo, A., Pombo, M., Casanueva, F.F. & Dieguez, C. (1993) Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. Journal of Clinical Endocrinology and Metabolism, 76, 168-171.
32. Pombo, M., Barreiro, J., Peñalva, A., Peino, R., Dieguez, C. & Casanueva, F.F. (1995) Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6) or GHRH plus GHRP-6, in children with neonatal pituitary stalk transaction. Journal of Clinical Endocrinology and Metabolism, 80, 3180-3184.
33. Popovic, V., Damjanovic, S., Micic, D., Djurovic, M., Dieguez, C. & Casanueva, F.F. (1995) Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. Journal of Clinical Endocrinology and Metabolism, 80, 942-947.
34. Popovic, V., Damjanovic, S., Micic, D., Petakov, M., Dieguez, C. & Casanueva, F.F. (1994) Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide. Journal of Clinical Endocrinology and Metabolism, 79, 456-460.
35. Renner, U., Brockmeier, S., Strasburger, C.J., Lange, M., Schopohl, J., Müller, O.A., Werder, Kv. & Stalla, O.K. (1994) Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. Journal of Clinical Endocrinology and Metabolism, 78, 1090-1096.
36. Rose, S.R., Ross, S.L., Uriarte, M., Barnes, K.M., Cassorla, F.G. & Cutler, J.B. (1988) The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. New England Journal of Medicine, 319, 201-207.
37. Rosenfeld, R.G., Albertsson-Wikland, K., Cassorla, F., Frasier, S.D., Hasegawa, Y., Hintz, R.L., Lafranchi, S., Lippe, B., Loriaux, L., Melmed, S., Preece, M.A., Ranke, M.B., Reiter, E.O., Rogol, A.D., Underwood, L.E. & Werther, G.A. (1995) Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited. Journal of Clinical Endocrinology Metabolism, 80, 1532-1540.
38. Ross, R.J.M., Tsagarakis, S., Grossman, A., Nhagabong, L., Touzel, R.J., Rees, L.H. & Besser, G.M. (1988) GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clinical Endocrinology, 27, 727-733.
39. 2 and human pancreatic growth hormone-releasing factor -44-NH2 in rat primary pituitary cell monolayer culture. Endocrinology, 116, 952-957.
40. Tassoni, P., Cacciari, E., Cau, M., Colli, C., Tosi, M.T., Zucchini, S., Cicognani, A., Pirazzoli, P., Salardi, S., Balsamo, A., Frejaville, E., Cassio, A. & Zappulla, F. (1990) Variability of growth hormone response to pharmacological and sleep tests performed twice in short children. Journal of Clinical Endocrinology and Metabolism, 71, 230-234.
41. Vance, M.L. (1993) Metabolic status and growth hormone secretion in man. Journal of Paediatric Endocrinology, 6, 3-4.
42. 2 in rats, dogs and monkeys. Life Sciences, 47, 29-36.
43. Walker, R.F., Yang, S.W. & Bercu, B.B. (1991) Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH). Life Sciences, 49, 1499-1504.